Références

1. Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptivecell-mediated effector immunity. J Allergy Clin Immunol 2 015 ; 135 : 626-35.

2. Nakahara T, Kido-NakaharaM,TsujiG, Furue M.Basics and recent advances in the pathophysiology of atopic dermatitis. J Dermato 2021 ; 48: 130-9.

3. Chiricozzi A, Maurelli M, Peris K, Girolomoni G. Targeting IL-4 for the Treatment of Atopic Dermatitis. Immunotargets Ther 2020 ; 9: 151-6.

4. Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol 2021 ; 126 : 21-31.

5. Lepe K, Zito PM. AlopeciaAreata. 2021 Nov. 15. In : StatPearls [Internet]. Treasure Island (FL) : StatPearls Publishing,Jan.2022.

6. Olayinka JJT, Richmond JM. Immunopathogenesis of alopecia areata. Curr Res Immunol 2021 ; 2: 7-11.

7. Martin L, Nicolas JF. Regulatory T cells control hair growth and prevent the development of alopecia areata. Med Sci (Paris) 2020 ; 36: 941-3.

8. Migayron L, BonifaceK, Seneschal J. Vitiligo, From Physiopathology to Emerging Treatments: A Review. Dermatol Ther (Heidelb) 2020 ; 10 : 1185-98.

9. Seneschal J, Boniface K, D’Arino A, Picardo M. An update on Vitiligo pathogenesis. Pigment Cell Melanoma Res 2021 ; 34: 236-43.

10. Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J. Qu’est-ce que l’hidradénite suppurée ? Can Fam Physician 2017 ; 63: e86-e93.



11. Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020 ; 6: 18.